Increased formation of the isoprostanes IPF(2α)-I and 8-Epi- prostaglandin F(2α) in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans

Circulation

Volumn 96, Issue 10, 1997, Pages 3314-3320

  Reilly, Muredach P ^a   Delanty, Norman ^a   Roy, Louis ^b   Rokach, Joshua ^c   Callaghan, Peter O ^d   Crean, Peter ^d   Lawson, John A ^a   FitzGerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c Florida Institute of Technology   (United States)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

Angioplasty; Lipids; Oxidant stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ISOPROSTANE IPF2 ALPHA 1; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY REPERFUSION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030862332     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3314     Document Type: Article

References (58)

1. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause or consequence? Lancet. 1994;344:721-724.
2. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol. 1993;21:53745.
3. Bolli R. Myocardial 'stunning' in man. Circulation. 1992;86: 1671-1691.
4. Sekili S, McCay PB, Li X-Y, Zughaib M, Sun J-Z, Tang L, Thornby JI, Bolli R. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial 'stunning' in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. Circ Res. 1993;73:705-723.
5. Li X-Y, McCay PB, Zughaib M, Jeroudi MO, Triana F, Bolli R. Demonstration of free radical generation in the 'stunned' myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest. 1993;92: 1025-1041.
6. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr. 1993;57(suppl): 715S-725S.
7. Holley AK, Cheeseman KH. Measuring free radical reactions in vivo. Br Med Bull. 1992;49:494-505.
8. Wade CR, van Rij AM. Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxyradicals on the quantitation of plasma lipid peroxides. Life Sci. 1988;43:1085-1093.
9. Yamamoto Y, Frei B, Ames B. Assay of lipid hydroperoxides using high performance liquid chromatography with isoluminol chemiluminesence detection. Methods Enzymol. 1990;186:371-80.
10. Grech ED, Dodd HF, Bellamy CM, Perry RA, Morrison WL, Ramsdale DR. Free radical generation during angioplasty reperfusion for acute myocardial infarction. Lancet. 1993;341:990-991.
11. Esterbauer H, Stnegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density Lipoprotein. Free Rad Res Commun. 1989;6:67-75.
12. Loft S, Astrup A, Buemann B, Poulsen HE. Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J. 1994;8:534-537.
13. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem. 1997;272:3520-3526.
14. Morrow JD, Roberts LJ II. The isoprostanes: current knowledge and directions for future research. Biochem Pharm. 1996;51:1-9.
15. 2α: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharm. 1996;42:15-19.
16. Morrow JD, Harris TM, Roberts LJ II. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem. 1990; 184:1-10.
17. Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF, Blair IA, Roberts LJ II. Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem. 1994;269: 4317-4326.
18. 2 isoprostanes formed by free radical oxidation of arachidonic acid. J Am Soc Mass Spectrom. 1996;7:490-499.
19. 2 receptors. J Clin Invest 1992;90:136-141.
20. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993;264: 1619-1624.
21. 2α. J Biol Chem. 1995;270:9800-9808.
22. 2α-I and its identification in biological fluids. Tetrahed Lett. 1996;37:4849-4852.
23. Reilly MP, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 1996;94:19-25.
24. 2α generation during coronary reperfusion: a potential quantitative marker of oxidant stress in vivo. Circulation. 1997;95:2492-2499.
25. Galli M, Marcassa C, Bolli R, Gianuzzi P, Temporelli PL, Imparato A, Silva Oreggo PL, Giubbini R, Giordano A, Tavazzi L. Spontaneous delayed recovery of reperfusion and contraction after the first 5 weeks after anterior infarction. Circulation. 1994;90: 1386-1397.
26. Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozi J, Armitage JM, Hardesty RL. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. JAm Coll Cardiol. 1990;15:1261-1269.
27. Coghlan JG, Flitters WD, Holley AK, Norell M, Mitchell AG, Isley CD, Slater TF. Detection of free radicals and cholesterol hydroperoxides in blood taken from the coronary sinus of man during percutaneous transluminal coronary angioplasty. Free Rad Res Commun. 1991;14:409-417.
28. Davies SW, Ranjadayalan K, Wickens DC, Dorinandy TL, Tinunis AD. Lipid peroxidation associated with successful thrombolysis. Lancet. 1990;335:741-743.
29. Purvis J, Young L Lightbody J, Trimble E, Adgey J. Free radical production following thrombolytic therapy in acute myocardial infarction. Circulation. 1992;86(suppl I):I-804. Abstract.
30. Coghlan JG, Flitter WD, Clutton SM, Panda R, Daly R, Wright G, Isley CD, Slater TF. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary bypass grafting. J Thorac Cardiovasc Surg. 1994;107:248-256.
31. Tortolani AJ, Powell SR, Misik V, Weglicki WB, Pogo GJ, Kramer JH. Detection of alkoxyl and carbon-centered free radicals in coronary sinus blood from patients undergoing elective cardioplegia. Free Rad Biol Med. 1993;14:421-426.
32. Ferrari R, Alfieri O, Curello S, Ceconi C, Cargnoni A, Marzollo P, Pardinni A, Caradonna E, Visioli O. Occurrence of oxidative stress during reperfusion of the human heart. Circulation. 1990;81: 201-211.
33. Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, George BS, Kereiakes DJ, Deitchrnan D, Gustafson N, Brinker JA, Becker LC, Mancini J, Topol E, Werns SW. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation. 1994;89: 1982-1991.
34. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD. N-Acetylcysteine in combination with nitroglycerin and streptokinase for the acute myocardial infarction. Circulation. 1995;92: 2855-2862.
35. Ohman EM, Slovak IP, Anderson RL, Grossman WJ, Barbeau GR, Butler JF, Frey MT, Talley DJ, Leimberger ID, Scherer JC, Kleiman NS. Potent inhibition of thrombin with Efegatran in combination with t-PA in acute myocardial infarction: results of a multicenter randomized dose ranging trial. Circulation. 1996; 94(suppl I):I-430. Abstract.
36. Llobat-Estelles M, Sevillano-Cabeja A, Campins-Falco P. Kinetic and chemometric studies of the determination of creatinine using the Jaffe reaction, part I: kinetics of the reaction: analytical conclusion. Analyst. 1989;114:597-602.
37. Karajounis L, Moreno F, Menlove RL, Ipsen S, Anderson JL. Effect of early thrombolytic therapy (anistrepase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction: TEAM-2 Investigators. Am J Cardiol. 1991;68:848-856.
38. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA.. 1992;89: 10721-10725.
39. Harrison KA, Murphy RC. Isoleukotrienes: biologically active free radical products of lipid peroxidation. J Biol Chem. 1995;270: 17273-17278.
40. Pratico D, Lawson J, FitzGerald GA. Isothromboxane formation by human monocytes. Blood. 1995;86:509. Abstract.
41. 2 receptors in human platelets. J Pharmacol Exp Ther. 1994;270:1192-1196.
42. 2α is not mediated by thromboxane receptor isoforms. J Biol Chem. 1996;271:14916-14924.
43. 2 isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332: 1198-1203.
44. 2-isoprostane) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J Clin Invest. 1992;90: 2502-2507.
45. Pratico D, Basili B, Cordova C, Iuliano L, Ferro D, Camastra C, FitzGerald GA, Violi F. Increased oxidant stress in liver cirrhosis. J Invest Med. 1996;44:301A. Abstract.
46. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health. 1989;79:158-162.
47. 2α by human monocytes. J Biol Chem. 1996:271:8919-8924.
48. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Maclouf J, Violi F, Fitzgerald GA. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest. 1997;100: 2028-2034.
49. FitzGerald DJ, Catella F, Roy L, Fitzgerald GA. Platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;77:142-150.
50. Kerins DM, Roy L, FitzGerald GA, Fitzgerald DJ. Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator. Circulation. 1989;80:1718-1725.
51. Braden G, Knapp HR, FitzGerald GA. Suppression of eicosanoid formation during coronary angioplasty by fish oil and aspirin. Circulation. 1991;83:679-685.
52. Reilly MP, Delanty N, Tremoli E, Rader D, FitzGerald GA. Elevated levels of 8-epi in familial hypercholesterolemia: evidence of oxidative stress in vivo. Circulation. 1996;94(suppl I):I-683. Abstract.
53. FitzGerald GA, Pedersen AC, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation. 1983;67:1174-1177.
54. Patrono C, Ciabattoni G, Pugliesse F, Pierucci A, Blair IA, FitzGerald GA. Estimated rate of thromboxane secretion into the circulation of normal man. J Clin Invest. 1986;77:590-594.
55. Hennekens CH, Buring JE, Peto R. Antioxidant vitamins: benefits not yet proved. N Engl J Med. 1994;330:1080-1081.
56. Hennekens CH, Buring JE, Manson J, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willet W, Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
57. Stephens NG, Parsons PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet. 1996;347:781-786.
58. 2α. J Pharmacol Exp Ther. 1995;275:94-100.